Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.
Kujas M, Lejeune J, Benouaich-Amiel A, Crinière E, Laigle-Donadey F, Marie Y, Mokhtari K, Polivka M, Bernier M, Chretien F, Couvelard A, Capelle L, Duffau H, Cornu P, Broët P, Thillet J, Carpentier AF, Sanson M, Hoang-Xuan K, Delattre JY. Kujas M, et al. Ann Neurol. 2005 Aug;58(2):322-6. doi: 10.1002/ana.20543. Ann Neurol. 2005. PMID: 16049942
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.
Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K. Kaloshi G, et al. Neurology. 2007 May 22;68(21):1831-6. doi: 10.1212/01.wnl.0000262034.26310.a2. Neurology. 2007. PMID: 17515545
MGMT methylation: a marker of response to temozolomide in low-grade gliomas.
Everhard S, Kaloshi G, Crinière E, Benouaich-Amiel A, Lejeune J, Marie Y, Sanson M, Kujas M, Mokhtari K, Hoang-Xuan K, Delattre JY, Thillet J. Everhard S, et al. Ann Neurol. 2006 Dec;60(6):740-3. doi: 10.1002/ana.21044. Ann Neurol. 2006. PMID: 17192931 Clinical Trial.
[Molecular biology of oligodendroglial tumors].
Laigle-Donadey F, Benouaich-Amiel A, Hoang-Xuan K, Sanson M. Laigle-Donadey F, et al. Neurochirurgie. 2005 Sep;51(3-4 Pt 2):260-8. doi: 10.1016/s0028-3770(05)83487-3. Neurochirurgie. 2005. PMID: 16292170 Review. French.
MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities.
Crinière E, Kaloshi G, Laigle-Donadey F, Lejeune J, Auger N, Benouaich-Amiel A, Everhard S, Mokhtari K, Polivka M, Delattre JY, Hoang-Xuan K, Thillet J, Sanson M. Crinière E, et al. J Neurooncol. 2007 Jun;83(2):173-9. doi: 10.1007/s11060-006-9320-0. Epub 2007 Jan 12. J Neurooncol. 2007. PMID: 17219056
41 results